Skip to content

Circadian System Heritability Assessed in Free Living Conditions

Circadian System Heritability Assessed in Free Living Conditions in a Twin Mediterranean Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03059576
Acronym
MTR
Enrollment
106
Registered
2017-02-23
Start date
2012-12-31
Completion date
2017-02-28
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Chronobiology, Circadian rhythms, Heritability, Twins

Brief summary

The purpose of this investigation is to assess the role of the genetic and environmental factor on circadian system, in free living conditions by the use of a female twin population. With the results from this study, the investigators expect to advance in the understanding of the role of the endogenicity of the circadian system variables such as temperature, activity, sleep and timing of food intake as the main cause of the coincidence of the rhythms. However, the investigators expected that some parameters are still dependent on environment to a relevant extent and, hence, amenable to change through external interventions.

Detailed description

Twin studies are a classic in the analysis of the relative contribution of genetic and environmental factors to behavior and other phenotypes. These models are most often used to separate genetic from environmental causes in the family resemblance methodology. These models based on twins have been previously carried out in chronobiology. In fact, during the years 1993 and 1994, Paul Linkowski et al., performed two relevant studies on the circadian system to analyze the relative contributions of hereditary and/or environmental factors of cortisol secretion and blood pressure, respectively, and concluded that genetic factors control some of the characteristics of cortisol and diastolic blood pressure circadian rhythmicity. The heritability of other circadian markers has also demonstrated such as morningness- eveningness (44%), sleep-related variables have also pointed to a relevant role of genetics with heritability estimates of sleep duration between 17% and 55%. However, to the investigators knowledge, the heritability of other relevant chronobiological markers, measured in free living conditions such as body temperature, actigraphy and sleep has not been studied. These goals will be achieved through a specific approach: * Observational (Aim 1): To study the potential effect of the genetic and environmental factor in the circadian system health in order to improve the chronobiological therapies in the clinical practice (n=106).

Interventions

OTHERChronobiological status of the subjects

Participation was completely voluntary and not remunerated. The subjects were organized into groups of 5 pairs, and were given an appointment at a university facility located in the city center, where informed consent was signed prior to the procedures indicated below. An informational letter was sent to pre-selected individuals. Later a phone call confirmed their availability. * Temperature rhythm was assessed continuously for 7 days using a temperature sensor and programmed to collect information every 10 min. * Body position and rest-activity rhythm were assessed over the same 7 days using a Acceleration Data Logger that record data every min and placed on the non-dominant arm by means of an elastic band, with its X axis parallel to the humerus bone. * Diet and sleep record were completed over the same week, their sleep schedules and their nutritional status.

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years

Inclusion criteria

IInclusion Criteria: * Body Mass Index: \>19 kg/m2 * Age: between 18 and 70 year of age * Caucasian

Exclusion criteria

* Receiving treatment with thermogenic, lipogenic, or contraceptive drugs * Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis * Bulimia diagnosis, prone to binge eating * Undergoing treatment with anxiolytic or antidepressant drugs

Design outcomes

Primary

MeasureTime frameDescription
Temperature recordTotal of 1 week between Visit 1 and 2Measured using temperature sensor
Actigraphy recordTotal of 1 week between Visit 1 and 2Measured using Pendant Acceleration Data Logger

Secondary

MeasureTime frameDescription
Light recordTotal of 1 week between Visit 1 and 2Measured using Pendant Acceleration Data Logger
Sleep recordTotal of 1 week between Visit 1 and 2Measured using Pendant Acceleration Data Logger

Other

MeasureTime frameDescription
Sleep DurationTotal of 1 week between Visit 1 and 2Sleep duration will be computed from self-reported
ChronotypeTotal of 1 week between Visit 1 and 2Assessed using the Morningness-Eveningness Questionnaire
Total Energy IntakeTotal of 1 week between Visit 1 and 2Total energy intake in kcal/day will be computed from 7-day 24-hr dietary recalls
Dietary CompositionTotal of 1 week between Visit 1 and 2Macronutrient and micronutrient intake will be computed from 7-days of self-reported 24-hr dietary recalls
Dietary Intake TimingTotal of 1 week between Visit 1 and 2Food timing will be self-reported and averaged across 7-days of 24-hr dietary recalls

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026